🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
This 2-part study will evaluate the effectiveness and side effects of two a...
Status
Completed
Location
National Institute of Dental And Craniofacial Research (NIDCR)
Start Date
1999-12
Trial ID
NCT00001955
Treatments Being Tested
That anti-TNF therapy and rituximab therapy are equally effective in treati...
Status
Completed
Location
NHS Fife
Start Date
2010-04
Trial ID
NCT01021735
Treatments Being Tested
The purpose of this study is to evalute the response and toxicity of metast...
Status
Completed
Location
The West Clinic
Start Date
2006-02
Trial ID
NCT00786643
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
1. assessment of the penefit of erythropoietin administration in decreasing...
Status
Unknown
Location
Multiple Locations
Start Date
2021-01-01
Trial ID
NCT04573686
Treatments Being Tested
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
The investigators plan to measure the health of the vascular system of subj...
Status
Completed
Location
Emory University
Start Date
2010-08
Trial ID
NCT01989689
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested